Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 48.29
(1.26%)
CNY 48.29
(1.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6 Billion CNY | -5.51% |
| 2022 | 6.35 Billion CNY | 28.53% |
| 2021 | 4.94 Billion CNY | 87.93% |
| 2020 | 2.63 Billion CNY | 39.63% |
| 2019 | 1.88 Billion CNY | 49.28% |
| 2018 | 1.26 Billion CNY | 54.41% |
| 2017 | 818.04 Million CNY | 11.58% |
| 2016 | 733.12 Million CNY | 12.64% |
| 2015 | 650.86 Million CNY | 35.23% |
| 2014 | 481.3 Million CNY | 28.29% |
| 2013 | 375.18 Million CNY | 36.45% |
| 2012 | 274.96 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.06 Billion CNY | -25.63% |
| 2024 Q2 | 1.43 Billion CNY | 6.34% |
| 2024 Q1 | 1.34 Billion CNY | -26.56% |
| 2023 FY | 6 Billion CNY | -5.51% |
| 2023 Q2 | 1.77 Billion CNY | 35.65% |
| 2023 Q1 | 1.3 Billion CNY | -35.98% |
| 2023 Q3 | 1.14 Billion CNY | -35.28% |
| 2023 Q4 | 1.83 Billion CNY | 59.9% |
| 2022 Q2 | 1.68 Billion CNY | 33.93% |
| 2022 Q4 | 2.03 Billion CNY | 47.22% |
| 2022 FY | 6.35 Billion CNY | 28.53% |
| 2022 Q3 | 1.38 Billion CNY | -17.59% |
| 2022 Q1 | 1.25 Billion CNY | -35.17% |
| 2021 Q3 | 1.07 Billion CNY | -7.27% |
| 2021 FY | 4.94 Billion CNY | 87.93% |
| 2021 Q1 | 776.68 Million CNY | -25.05% |
| 2021 Q2 | 1.15 Billion CNY | 49.34% |
| 2021 Q4 | 1.93 Billion CNY | 79.95% |
| 2020 Q3 | 649.16 Million CNY | 12.04% |
| 2020 Q1 | 367.89 Million CNY | -38.45% |
| 2020 Q2 | 579.38 Million CNY | 57.49% |
| 2020 FY | 2.63 Billion CNY | 39.63% |
| 2020 Q4 | 1.03 Billion CNY | 59.64% |
| 2019 Q1 | 355.46 Million CNY | -10.83% |
| 2019 Q3 | 478.54 Million CNY | 5.45% |
| 2019 FY | 1.88 Billion CNY | 49.28% |
| 2019 Q4 | 597.71 Million CNY | 24.9% |
| 2019 Q2 | 453.83 Million CNY | 27.67% |
| 2018 FY | 1.26 Billion CNY | 54.41% |
| 2018 Q4 | 398.65 Million CNY | 31.23% |
| 2018 Q3 | 303.77 Million CNY | -10.4% |
| 2018 Q2 | 339.02 Million CNY | 20.93% |
| 2018 Q1 | 280.35 Million CNY | 0.0% |
| 2017 Q2 | 195.23 Million CNY | 0.0% |
| 2017 Q1 | 195.23 Million CNY | -8.35% |
| 2017 FY | 818.04 Million CNY | 11.58% |
| 2016 Q4 | 213.02 Million CNY | 0.0% |
| 2016 Q2 | 209.17 Million CNY | 0.0% |
| 2016 FY | 733.12 Million CNY | 12.64% |
| 2016 Q3 | 213.02 Million CNY | 1.84% |
| 2016 Q1 | 209.17 Million CNY | 23.45% |
| 2015 Q4 | 169.43 Million CNY | 0.0% |
| 2015 FY | 650.86 Million CNY | 35.23% |
| 2015 Q3 | 169.43 Million CNY | 8.61% |
| 2015 Q2 | 156 Million CNY | 0.0% |
| 2015 Q1 | 156 Million CNY | 31.39% |
| 2014 Q1 | 121.92 Million CNY | 28.44% |
| 2014 Q3 | 118.72 Million CNY | -2.62% |
| 2014 FY | 481.3 Million CNY | 28.29% |
| 2014 Q4 | 118.72 Million CNY | 0.0% |
| 2014 Q2 | 121.92 Million CNY | 0.0% |
| 2013 Q2 | 92.66 Million CNY | 0.0% |
| 2013 Q3 | 94.92 Million CNY | 2.44% |
| 2013 Q4 | 94.92 Million CNY | 0.0% |
| 2013 FY | 375.18 Million CNY | 36.45% |
| 2013 Q1 | 92.66 Million CNY | 41.34% |
| 2012 FY | 274.96 Million CNY | 0.0% |
| 2012 Q4 | 65.56 Million CNY | 0.0% |
| 2012 Q3 | 65.56 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |